DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
05/03/2023* -- Results Q1 2023 -- 1.02 --
05/03/2023* 17:00 EST Earnings Call Q1 2023 -- -- --
02/14/2023 -- Results Q4 2022 1.70 1.66 2.34%
02/14/2023 08:00 EST Earnings Call Q4 2022 -- -- --
11/08/2022 -- Results Q3 2022 1.51 1.48 2.37%
11/08/2022 08:00 EST Earnings Call Q3 2022 -- -- --
08/04/2022 -- Results Q2 2022 2.32 2.01 15.49%
08/04/2022 08:00 EST Earnings Call Q2 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 05/03/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 02/14/2023
Beat/Miss Upgrade
Return Since -3.41%
Last FQE 12/31/2022
Next FQE 03/31/2023

Profile

PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
URL https://www.perkinelmer.com
Investor Relations URL https://ir.perkinelmer.com/
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Blend
Next Earnings Release May. 03, 2023 (est.)
Last Earnings Release Feb. 14, 2023
Next Ex-Dividend Date Apr. 20, 2023
Last Ex-Dividend Date Jan. 19, 2023

Dividends

Dividend Per Share (TTM) 0.28
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.1568
Yield to Sector 23.09
Yield to Industry 0.6359
Last Dividend Amt. 0.07
Dividend Frequency Quarterly
Last Ex-Dividend Date Jan. 19, 2023
Yield (TTM) 0.21%
Forward Yield 0.21%
Payout Ratio 6.21%
Cash Payout Ratio 5.95%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
-2.12%
40.85%
7.80%
24.01%
48.19%
40.37%
-30.13%
-4.91%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
7.50%
10.15%
48.32%
1.67%
27.53%
39.77%
35.51%
-5.53%
-7.56%
51.60%
-66.50%
98.53%
87.59%
140.4%
-36.86%
-81.13%
23.96%
3.70%
6.56%
-3.86%
27.03%
39.49%
5.12%
-2.29%
7.86%
-12.16%
62.96%
-12.82%
71.85%
6.58%
55.36%
-18.29%
15.40%
As of March 31, 2023.

Profile

PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
URL https://www.perkinelmer.com
Investor Relations URL https://ir.perkinelmer.com/
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Blend
Next Earnings Release May. 03, 2023 (est.)
Last Earnings Release Feb. 14, 2023
Next Ex-Dividend Date Apr. 20, 2023
Last Ex-Dividend Date Jan. 19, 2023

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
MJJ 2.653M USD 5.42%
THCX 996852.0 USD 4.18%
BBHLX 93.31M USD 4.09%
PINK 858163.0 USD 2.04%
PACLX 822.83M USD 1.81%
F00000Z1XG 196.34M USD 1.80%
RYH 15.56M USD 1.60%
ITCTX 119.22M USD 1.58%
HTEC 1.569M USD 1.57%
GURU 679997.0 USD 1.48%
MCPRX 192.79M USD 1.46%
CAFFX 759.39M USD 1.16%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter PKI Tweets